Global Ultrasound Gel Market was valued at approximately USD 97.9 million in 2023 and is anticipated to grow with a healthy growth rate of more than 2.9% over the forecast period 2024-2032. Ultrasound gel, a coupling agent used in ultrasound imaging, facilitates the transmission of ultrasound waves to the tissues, aiding in the creation of clear and accurate images. The increasing adoption of ultrasound imaging, attributed to its cost-effectiveness, ease of use, and safety compared to other imaging methods, is driving the market growth. Additionally, the rising awareness towards screening for breast cancer and the increase in the target population are expected to contribute to market expansion.

The market growth is further bolstered by the surge in the procedural volume of ultrasound globally, coupled with rapid technological advancements in ultrasound gels. The availability of handheld ultrasound devices at reasonable prices has encouraged their adoption in small-sized clinics and hospitals, presenting significant growth opportunities. However, factors such as the cooling effect of ultrasound gels and inadequate healthcare resources are expected to impede market growth. The presence of surgical lube as an alternative to ultrasound gel also poses a challenge.

North America dominated the market in 2023, accounting for the largest revenue share of 39.2%, driven by the presence of major market players, developed healthcare infrastructure, and favorable reimbursement policies. The region's market growth is further supported by the increasing acceptance of ultrasound at community-level clinics and home healthcare. Asia Pacific is expected to grow at the fastest CAGR of 3.8% during the forecast period, fueled by large unmet needs, developing healthcare facilities, and the presence of several small-scale domestic manufacturers in countries like China and India.

Major market players included in this report are:
Compass Health Brands
ECO-MED
National Therapy Products
H.R Pharmaceuticals Inc
Tele-Paper Malaysia
Sonogel Vertriebs
Medline Industries, Inc.
Parker Laboratories
Ultragel Kft.
The X-Ray Shoppe
The detailed segments and sub-segment of the market are explained below:
By Type:
Non-sterile
Sterile
By End Use:
Hospitals
Clinics
Diagnostic Center
Ambulatory Center
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.